Zai Lab Limited (NASDAQ: ZLAB) Investor Alert: Investigation Over Possible Violations of Securities Laws

An investigation for investors in Zai Lab Limited (NASDAQ: ZLAB) shares over potential securities laws violations by Zai Lab Limited was announced.

San Diego, CA — (SBWIRE) — 04/25/2022 — Zai Lab Limited is under investigation over potential securities laws violations by Zai Lab Limited in connection with certain financial statements.

Investors who purchased shares of Zai Lab Limited (NASDAQ: ZLAB), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The investigation by a law firm focuses on whether a series of statements by Zai Lab Limited regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

China based Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. Zai Lab Limited reported that its annual Total Revenue rose from $48.95 million in 2020 to $144.31 million in 2021, and that its Net Loss increased from $268.9 million in 2020 to $704.47 million in 2021.

On March 9, 2022, the U.S. Securities and Exchange Commission (“SEC”) published a notification identifying Zai Lab Limited, among other companies, as in potential violation of the Holding Foreign Companies Accountable Act, which allows the SEC to delist companies and ban a company’s shares from being traded if the company fails to allow U.S. regulators to review their company audits for three straight years. Zai Lab Limited and the other companies named in the SEC notification have until March 29, 2022 to challenge the charges against them.

Those who purchased shares of Zai Lab Limited (NASDAQ: ZLAB) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.sbwire.com/press-releases/zai-lab-limited-nasdaq-zlab-investor-alert-investigation-over-possible-violations-of-securities-laws-1356582.htm

Media Relations Contact

Christopher Clausen
Shareholders Foundation
Telephone: 1-858-779-1554
Email: Click to Email Christopher Clausen
Web: http://www.ShareholdersFoundation.com